Enzo Biochem Inc. (ENZ): Prakiraan wutah bathi resik saben saham kanggo taun ngarep

Logo korporat perusahaan Enzo Biochem Inc. (ENZ)

High barriers to entry are ensured by strict FDA control and DNA labeling patents for Enzo Biochem, Inc. (ENZ). Currently, the business relies on the production of reagents for molecular analysis. The projected earnings per share growth target helps identify the asset's undervaluation phase, while 0.00 reflects the latest value of the metric. Vertical integration and proprietary developments in genomics make the company an independent innovation center.

ENZ - Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep Enzo ing rentang 04.07.2022 - 26.04.2025
Produk merek Enzo Biochem

The scientific authority of Enzo Biochem, Inc. (ENZ) in molecular diagnostics allows experts to extrapolate the demand for innovative tests into future financial results. By analyzing expectations for the company's EPS growth next year, investors assess profit sensitivity to macroeconomic shifts, utilizing this chart to identify trend reversal points and verify the resilience of the business model in a changing environment.

Analisis pesaing

A (Agilent Tech) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Quest Corp DGX|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Illumina, Inc. (ILMN)|exactsciences.com - Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep|Revvity - Prakiraan wutah bathi saben saham kanggo taun ngarep|BIO (Bio-Rad Laboratories, Inc.) - Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep|NNNN - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Nordion|QDEL (QuidelOrtho) - Prakiraan wutah bathi saben saham kanggo taun ngarep|opko.com - Dinamika bathi saben saham sing diarepake ing taun ngarep|CDNA (CareDx, Inc.) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep MRVI|Prakiraan wutah bathi kanggo taun ngarep FLGT|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Standard BioTools Corp|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Cytek Biosciences, Inc. CTKB|orasure.com (OSUR) - Prakiraan wutah bathi resik saben saham ing taun ngarep|Exagen Diagnostics - Prakiraan wutah bathi kanggo taun ngarep|MDxHealth S.A. (MDXH) - Prakiraan wutah bathi saben saham kanggo taun ngarep|LUCD: Prakiraan wutah bathi kanggo taun ngarep|Prenetics - Dinamika bathi saben saham sing diarepake ing taun ngarep|IMDX (Insight Molecular Diagnostics, Inc.) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Trinity Biotech Corp TRIB|Prakiraan wutah bathi resik saben saham kanggo taun ngarep ProPhase Labs (PRPH)|Prakiraan wutah bathi saben saham kanggo taun ngarep Ainos Inc AIMD|Co-Diagnostics Corp - Prakiraan wutah bathi saben saham kanggo taun ngarep|Dinamika bathi saben saham sing diarepake ing taun ngarep HSCS|Biomerica, Inc. - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Cardio Diagnostics CDIO|Onconetix (ONCO) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep VRAX|BJDX (Bluejay) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi saben saham kanggo taun ngarep Aspira Women's Health Inc (AWH)|Prakiraan wutah bathi saben saham kanggo taun ngarep AXDX (Accelerate Diagnostics)|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep CENTOGENE, N.V.|Prakiraan wutah bathi kanggo taun ngarep FRES (Fresh2 Group)|Genetic Technologies Ltd (GENE) - Prakiraan wutah bathi resik saben saham ing taun ngarep|ME - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|PMD (Psychemedics Inc) - Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep